Stop Paying PBM Retail Markups. Audit Real Drug Costs & Top-Decile Local MDs.

Cluster of central visceral adiposity, fasting hyperinsulinemia, elevated triglycerides, depressed HDL-C, and systemic vascular hypertension driving cardiometabolic morbidity.

Progressive skeletal muscle and hepatic insulin resistance paired with pancreatic beta-cell secretory exhaustion requiring multi-pathway glycemic and cardiorenal protection.

Preventive geroscience protocols targeting nutrient-sensing pathways, autophagic proteostasis, mitochondrial biogenesis, and inflammaging suppression.

Biochemically confirmed low morning serum total and free testosterone accompanied by somatic, sexual, hematologic, and neurocognitive symptoms.

Ovarian follicular depletion producing erratic and declining 17-beta-estradiol and progesterone levels, triggering vasomotor instability, sleep fragmentation, urogenital atrophy, and accelerated trabecular bone loss.

Dihydrotestosterone-mediated progressive miniaturization of terminal scalp hair follicles across frontotemporal and vertex distributions in genetically susceptible men and women.

Pilosebaceous follicular hyperkeratinization and Cutibacterium acnes inflammation alongside UV-induced dermal collagenase upregulation and epidermal dysplasia.

Excess circulating apolipoprotein B-containing lipoproteins (LDL, VLDL remnants, Lp(a)) driving subendothelial arterial retention and atherosclerotic plaque progression.

Sustained systemic arterial blood pressure elevation increasing left ventricular afterload, cerebral microvascular shear, and glomerular barotrauma.